Form 424B5 - Prospectus [Rule 424(b)(5)]:
SEC Accession No. 0001140361-24-031588
Filing Date
2024-06-27
Accepted
2024-06-27 16:42:21
Documents
6

Document Format Files

Seq Description Document Type Size
1 424B5 ny20031755x1_424b5.htm 424B5 602106
2 logo_eliciox1.jpg GRAPHIC 33082
3 logo_eliciox2.jpg GRAPHIC 28117
4 logo_eliciox3.jpg GRAPHIC 56842
5 logo_jonesx1.jpg GRAPHIC 25551
6 logo_jonesx2.jpg GRAPHIC 13580
  Complete submission text file 0001140361-24-031588.txt   818865
Mailing Address 451 D STREET, 5TH FLOOR BOSTON MA 02210
Business Address 451 D STREET, 5TH FLOOR BOSTON MA 02210 (857) 209-0050
Elicio Therapeutics, Inc. (Filer) CIK: 0001601485 (see all company filings)

EIN.: 113430072 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B5 | Act: 33 | File No.: 333-279925 | Film No.: 241079852
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)